Hua Wang (RBTE), a professor of Materials Science and Engineering, and his research group are passionate about developing novel – but simple – solutions to not only improve the efficacy of cancer immunotherapies, but also to look ahead to clinical translation.

Researchers have demonstrated a novel two-step strategy to label and eradicate cancer stem-like cells (CSC) to improve cancer treatment prognosis.

An Illinois research team led by scientist Hua Wang (RBTE), a professor of materials science and engineering, has developed a biomaterial for T cell immunotherapy that can stimulate and expand function T cells in the body.

Hua Wang (RBTE), a Materials Science and Engineering assistant professor, was recently awarded a 2.26M Research Project grant from the National Cancer Institute, which will support the development of type 1 conventional dendritic cells (cDC1) targeted cancer vaccines and cytokine therapies through the integration of immune cell homing materials and metabolic glycan labeling.